Archive Newsletter

41. 12.18.24 -- Enhancing Biotech Efficacy And Accelerating mRNA Development 12/18/2024

    12/18/24 Advancing RNA Newsletter

42. 12.18.24 -- "Ghosts of mRNA Past & Present:" 6 RNA Execs Revisit 2024 12/18/2024
    12/18/24 Advancing RNA Newsletter
43. 12.12.24 -- How To Ensure 21 CFR Part 11 Compliance 12/12/2024

    12/12/24 Advancing RNA Newsletter

44. 12.12.24 -- All Eyes On Sustainability 12/12/2024

    12/12/24 Advancing RNA Newsletter

45. 12.11.24 -- Pushing Drug Development Forward With mRNA Expertise 12/11/2024

    12/11/24 Advancing RNA Newsletter

46. 12.11.24 -- Navigating the "Holy Trinity" of RNA Structure, Process, & Biology 12/11/2024
    12/11/24 Advancing RNA Newsletter
47. 12.04.24 -- How Platform Technologies Are Shaping The Gene Therapy Landscape 12/4/2024
    12/04/24 Advancing RNA Newsletter
48. 11.27.24 -- Tackling Standardization For mRNA Therapeutics 11/27/2024
    11/27/24 Advancing RNA Newsletter
49. 11.25.24 -- Oligonucleotide Synthesizers That Take You From Start To Finish 11/25/2024
    11/25/24 Advancing RNA Newsletter
50. 11.20.24 -- Tips For Addressing Vaccine Demand – Strategies For C&G And mRNA 11/20/2024

    11/20/24 Advancing RNA Newsletter